NEWS
Gene Weaver selected as ARIA R&D Creator to tackle 50-year-old mitochondrial engineering challenge
Gene Weaver Ltd has been selected as an R&D Creator on the Advanced Research + Invention Agency’s (ARIA) Precision Mitochondria programme, a national, multi-year...
The UK can build a bioeconomy that works for people, planet and business
By Jen Vanderhoven, CEO of the BBIA and the BioRevolution Coalition.
Every day, we use products that depend on fossil resources without giving it much...
Biotechnology
AI Can’t Create What It Doesn’t Know: Why Inputs Matter
AI can analyse evidence faster than ever, but primary research with customers still creates the evidence pharmaceutical companies require for strategic decision making, says...
The biggest barrier to AI in life sciences isn’t the AI
Only 12% of agentic AI initiatives reached production over the past year. The challenge isn’t the technology, but ensuring AI can operate within highly...
Drug Discovery
Are animal models limiting progress in product development?
Toxicity Testing in the 21st Century (TT21C) is helping to reshape biological testing by focusing on the mechanisms that drive toxicity and disease.
Matt Stevenson,...
Turbocharging ‘good’ viruses to destroy bacteria
Scientists at the University of Leicester have developed a new technique that will turbocharge the use of phages for medicinal purposes.
The pioneering technique uses...
